These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 27161693)

  • 1. PO-05 - Incidence of venous thromboembolism (VTE) in bile duct tumors (BDT) treated with chemotherapy in ambulatory setting.
    Adrián SG; de Castro EM; Olmos VP; Martín MN; Del Prado PM; Mena ML; Ramírez OR; Lavín DC; Arteaga JF; Martín AJ
    Thromb Res; 2016 Apr; 140 Suppl 1():S178. PubMed ID: 27161693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
    Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
    Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OC-14 - Baseline D-dimer levels are predictive of recurrent venous thromboembolism (VTE) at 6 months in cancer patients with VTE treated with tinzaparin.
    Piatek CI; Tagawa ST; Wei-Tsai D; Hanna D; Weitz IC; O'Connell C; Rochanda L; Groshen S; Liebman HA
    Thromb Res; 2016 Apr; 140 Suppl 1():S174. PubMed ID: 27161687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment-related frequency of venous thrombosis in lower esophageal, gastro-esophageal and gastric cancer--a clinical prospective study of outcome and prognostic factors.
    Larsen AC; Frøkjær JB; Fisker RV; Iyer V; Mortensen PB; Yilmaz MK; Møller B; Kristensen SR; Thorlacius-Ussing O
    Thromb Res; 2015 May; 135(5):802-8. PubMed ID: 25743885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis.
    García Adrián S; González AR; de Castro EM; Olmos VP; Morán LO; Del Prado PM; Fernández MS; Burón JDC; Escobar IG; Galán JM; Pérez AIF; Neria F; Lavin DC; Hernández BLSV; Jiménez-Fonseca P; Muñoz Martín AJ
    Eur J Intern Med; 2022 Nov; 105():30-37. PubMed ID: 35931614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OC-11 - Anticoagulation therapy in selected cancer patients at risk of recurrence of venous thromboembolism.
    Young A; Phillips J; Hancocks H; Hill C; Joshi N; Marshall A; Grumett J; Dunn JA; Lokare A; Chapman O
    Thromb Res; 2016 Apr; 140 Suppl 1():S172-3. PubMed ID: 27161683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OC-01 - Clinical history of cancer patients with isolated distal deep vein thrombosis: a multicenter cohort study.
    Dentali F; Pegoraro S; Barco S; di Minno MN; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti S; Benedetti R; Ageno W; Nisio MD
    Thromb Res; 2016 Apr; 140 Suppl 1():S168. PubMed ID: 27161673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated calf muscular vein thrombosis is associated with pulmonary embolism and a high incidence of additional ipsilateral and contralateral deep venous thrombosis.
    Kret MR; Liem TK; Mitchell EL; Landry GJ; Moneta GL
    J Vasc Surg Venous Lymphat Disord; 2013 Jan; 1(1):33-8. PubMed ID: 26993891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism in patients with cholangiocarcinoma: focus on risk factors and impact on survival.
    Jeon HK; Kim DU; Baek DH; Ha DW; Lee BE; Ryu DY; Cheong JH; Kim GH; Song GA; Jang AL
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):444-9. PubMed ID: 22410715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
    Otten HM; Mathijssen J; ten Cate H; Soesan M; Inghels M; Richel DJ; Prins MH
    Arch Intern Med; 2004 Jan; 164(2):190-4. PubMed ID: 14744843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of venous thromboembolism is not lowin Korean patients with advanced pancreatic cancer [corrected].
    Yoon SY; Lee MY; Yun J; Yoon J; Kim HJ; Kim KH; Kim SH; Lee SC; Bae SB; Kim CK; Lee N; Lee NS; Lee KT; Park SK; Hong DS; Won JH
    Blood Res; 2018 Sep; 53(3):227-232. PubMed ID: 30310790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, risk factors and clinical features of venous thromboembolism in newly diagnosed lymphoma patients: results from a prospective cohort study with Asian population.
    Park LC; Woo SY; Kim S; Jeon H; Ko YH; Kim SJ; Kim WS
    Thromb Res; 2012 Sep; 130(3):e6-12. PubMed ID: 22507288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic and incidental thromboembolism are both associated with mortality in pancreatic cancer.
    Menapace LA; Peterson DR; Berry A; Sousou T; Khorana AA
    Thromb Haemost; 2011 Aug; 106(2):371-8. PubMed ID: 21713322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort.
    Mancuso A; Vedovati MC; Pierpaoli L; Paliani U; Conti S; Filippucci E; Ascani A; Radicchia S; Galeotti G; Agnelli G; Becattini C
    Thromb Res; 2016 Apr; 140 Suppl 1():S191. PubMed ID: 27161728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of recurrent thrombosis in subsets of cancer patients with isolated gonadal vein thrombosis: a single center retrospective study.
    Tanasanvimon S; Garg N; Viswanathan C; Truong M; Kaur H; Kee BK; Sahin IH; Javle MM; Garrett CR
    Thromb Res; 2014 Feb; 133(2):154-7. PubMed ID: 24331209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low incidence of symptomatic thromboembolic events after total ankle arthroplasty without routine use of chemoprophylaxis.
    Horne PH; Jennings JM; DeOrio JK; Easley ME; Nunley JA; Adams SB
    Foot Ankle Int; 2015 Jun; 36(6):611-6. PubMed ID: 25712115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Deep venous thrombosis as a marker of tumor recurrence].
    Blanch Alerany M; Calvo Campos M; Romera Villegas A; Pérez-Piqueras Gómez A; Riera Batalla S; Cairols Castellote MA
    Med Clin (Barc); 2009 Oct; 133(14):529-32. PubMed ID: 19656530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptomatic perioperative venous thromboembolism is a frequent complication in patients with a history of deep vein thrombosis.
    Liem TK; Huynh TM; Moseley SE; Minjarez RC; Landry GJ; Mitchell EL; Deloughery TG; Moneta GL
    J Vasc Surg; 2010 Sep; 52(3):651-7. PubMed ID: 20558025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.